Cargando…

Telomeropathy in Chronic Hypersensitivity Pneumonitis

Detalles Bibliográficos
Autores principales:	Bouros, Demosthenes, Tzouvelekis, Argyrios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2019
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888653/ https://www.ncbi.nlm.nih.gov/pubmed/31390879 http://dx.doi.org/10.1164/rccm.201907-1483ED

Ejemplares similares

Clinical experience with antifibrotics in fibrotic hypersensitivity pneumonitis: a 3-year real-life observational study
por: Tzilas, Vasilios, et al.
Publicado: (2020)

Nandrolone decanoate: new therapeutic option for telomeropathies?
por: Frieri, Camilla
Publicado: (2023)

Estrogen Signaling and MicroRNAs in Lung Fibrosis. Sex, Hormones, and Rock Scars
por: Tzouvelekis, Argyris, et al.
Publicado: (2019)

Telomeropathies: An emerging spectrum disorder
por: Holohan, Brody, et al.
Publicado: (2014)

Chronic hypersensitivity pneumonitis; an enigmatic and frequently fatal disease
por: Maher, Toby M.
Publicado: (2020)

False Positive COVID-19 Antibody Test in a Case of Granulomatosis With Polyangiitis
por: Tzouvelekis, Argyrios, et al.
Publicado: (2020)

Cystic lung disease in Birt-Hogg-Dubé syndrome. A case series
por: Tzilas, Vasilios, et al.
Publicado: (2020)

Formoterol in the management of chronic obstructive pulmonary disease
por: Steiropoulos, Paschalis, et al.
Publicado: (2008)

Chronic hypersensitivity pneumonitis
por: Pereira, Carlos AC, et al.
Publicado: (2016)

Hypersensitivity pneumonitis: An infrequent cause of chronic lung fibrosis in Africa?
por: Wong, M L
Publicado: (2022)

Metabolic Disorders in Chronic Lung Diseases
por: Papaioannou, Ourania, et al.
Publicado: (2018)

Endotyping of progressive fibrotic interstitial lung diseases: It is the final destination that matters and not the journey
por: Tzouvelekis, Argyris, et al.
Publicado: (2020)

Hypersensitivity pneumonitis
por: Lacasse, Yves, et al.
Publicado: (2006)

Transbronchial biopsy in chronic hypersensitivity pneumonitis
por: Botelho, Andre B., et al.
Publicado: (2021)

Prognostic factors in chronic hypersensitivity pneumonitis
por: Creamer, Andrew W., et al.
Publicado: (2020)

Angiogenesis in Interstitial Lung Diseases: a pathogenetic hallmark or a bystander?
por: Tzouvelekis, Argyris, et al.
Publicado: (2006)

Application of microarray technology in pulmonary diseases
por: Tzouvelekis, Argyris, et al.
Publicado: (2004)

Serum biomarkers in Acute Respiratory Distress Syndrome an ailing prognosticator
por: Tzouvelekis, Argyris, et al.
Publicado: (2005)

The Role of Hydroxychloroquine in Coronavirus Disease 2019. A Versatile Tool at the Service of Humanity
por: Tzouvelekis, Argyris, et al.
Publicado: (2020)

Hypersensitivity pneumonitis: the importance of the radiologist in the multidisciplinary approach to its diagnosis
por: Nobre, Luiz Felipe, et al.
Publicado: (2016)

COVID-19, A Clinical Syndrome Manifesting as Hypersensitivity Pneumonitis
por: Song, Young Goo, et al.
Publicado: (2020)

Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis
por: Adegunsoye, Ayodeji, et al.
Publicado: (2017)

Use of leflunomide in patients with chronic hypersensitivity pneumonitis
por: Noh, Sungryong, et al.
Publicado: (2020)

Comorbidities and survival in patients with chronic hypersensitivity pneumonitis
por: Wälscher, Julia, et al.
Publicado: (2020)

Successful treatment of telomeropathy‐related interstitial lung disease with immunosuppression and danazol
por: Chambers, Daniel C., et al.
Publicado: (2020)

Mesenchymal Stem Cells for the Treatment of Idiopathic Pulmonary Fibrosis
por: Tzouvelekis, Argyrios, et al.
Publicado: (2018)

Serum biomarkers in interstitial lung diseases
por: Tzouvelekis, Argyris, et al.
Publicado: (2005)

Pneumomediastinum as a primary manifestation of chronic hypersensitivity pneumonitis
por: Koschel, Dirk, et al.
Publicado: (2011)

Mechanisms of exercise limitation in patients with chronic hypersensitivity pneumonitis
por: Dias, Olívia Meira, et al.
Publicado: (2018)

Cockatiel-induced hypersensitivity pneumonitis.
por: McCluskey, James D, et al.
Publicado: (2002)

Dabbing-Induced Hypersensitivity Pneumonitis
por: Haddad, Ibrahim, et al.
Publicado: (2021)

Cut from the Same Cloth: Similarities between Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis
por: Yang, Monica M., et al.
Publicado: (2021)

Effect and Safety of Mycophenolate Mofetil in Idiopathic Pulmonary Fibrosis
por: Tzouvelekis, Argyris, et al.
Publicado: (2011)

Hypersensitivity Pneumonitis Associated with Red-Vented Bulbul: A New Encounter of Bird Related Hypersensitivity Pneumonitis
por: Amarasinghe, W. D. N. L., et al.
Publicado: (2019)

Increased Red Cell Distribution Width Is Associated With Disease Severity in Hospitalized Adults With SARS-CoV-2 Infection: An Observational Multicentric Study
por: Karampitsakos, Theodoros, et al.
Publicado: (2020)

Autoimmune Hypothyroidism As a Predictor of Mortality in Chronic Hypersensitivity Pneumonitis
por: Adegunsoye, Ayodeji, et al.
Publicado: (2017)

Use of interrupter technique in assessment of bronchial responsiveness in normal subjects
por: Panagou, Panagiotis, et al.
Publicado: (2004)

Lung Cancer and Interstitial Lung Diseases: A Systematic Review
por: Archontogeorgis, Kostas, et al.
Publicado: (2012)

Diagnosis of Idiopathic Pulmonary Fibrosis “Pragmatic Challenges in Clinical Practice”
por: Tzilas, Vasilios, et al.
Publicado: (2017)

Hypersensitivity Pneumonitis Mortality by Industry and Occupation
por: Hall, Noemi B., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_900gs8aku4opfvbt5d9soudp8g